SBIR-STTR Award

Magnetic Neural Stimulator for Neurophysiology
Award last edited on: 12/29/2011

Sponsored Program
SBIR
Awarding Agency
NIH : NINDS
Total Award Amount
$650,000
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Joseph Sgro

Company Information

Alacron Inc (AKA: Corteks)

71 Spit Brook Road Suite 200
Nashua, NH 03060
   (603) 891-2750
   sales@alacron.com
   www.alacron.com
Location: Single
Congr. District: 02
County: Hillsborough

Phase I

Contract Number: 1R43NS024924-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1987
Phase I Amount
$50,000
Corteks proposes to develop a high speed, compact, moderately priced, magnetic neural stimulator for neurophysiology. The device will overcome major limitations of presently available magnetic stimulators by permitting restriction of stimulation to limited regions of neural tissue, and by allowing stimulation at higher rates. Major clinical applications will include diagnostic and intraoperative evaluation of efferent pathways, as well as possible in vivo selective fiber stimulation. The feasibility of stimulating restricted areas of neural tissue, and achieving high rates of stimulation was demonstrated in Phase I. In Phase II, we will perform experiments to determine optimum stimulation parameters, build an optimized stimulator, and test the device for both effectiveness and safety

Phase II

Contract Number: 2R44NS024924-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1989
(last award dollars: 1990)
Phase II Amount
$600,000

Corteks proposes to develop a high speed, compact, moderately priced, magnetic neural stimulator for neurophysiology. The device will overcome major limitations of presently available magnetic stimulators by permitting restriction of stimulation to limited regions of neural tissue, and by allowing stimulation at higher rates. Major clinical applications will include diagnostic and intraoperative evaluation of efferent pathways, as well as possible in vivo selective fiber stimulation. The feasibility of stimulating restricted areas of neural tissue, and achieving high rates of stimulation was demonstrated in Phase I. In Phase II, we will perform experiments to determine optimum stimulation parameters, build an optimized stimulator, and test the device for both effectiveness and safety